Issue 38, 2014

A biodegradable polymer platform for co-delivery of clinically relevant oxaliplatin and gemcitabine

Abstract

Anticancer drugs of gemcitabine and oxaliplatin combined in a clinic regimen (GEMOX regimen) were co-loaded to a biodegradable polymer platform for drug delivery.

Graphical abstract: A biodegradable polymer platform for co-delivery of clinically relevant oxaliplatin and gemcitabine

Article information

Article type
Paper
Submitted
28 Apr 2014
Accepted
26 Jul 2014
First published
30 Jul 2014

J. Mater. Chem. B, 2014,2, 6560-6570

Author version available

A biodegradable polymer platform for co-delivery of clinically relevant oxaliplatin and gemcitabine

H. Song, H. Xiao, M. Zheng, R. Qi, L. Yan and X. Jing, J. Mater. Chem. B, 2014, 2, 6560 DOI: 10.1039/C4TB00678J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements